Monitor whether the company has regained compliance with Nasdaq minimum bid price rules following the reverse split. The $3M market cap and history of previous reverse splits suggest ongoing capital structure challenges. No immediate trading catalyst from this administrative event.
Price Chart
Executive Summary
Shuttle Pharmaceuticals filed a Certificate of Amendment to effect a 1-for-10 reverse stock split of its common stock, effective June 11, 2026. The split was approved by shareholders on May 21, 2026, and authorized by the board on June 1, 2026. This is a routine capital structure adjustment with no change to the company's market capitalization, authorized shares, or underlying business fundamentals.
Key Facts
- Reverse stock split at a 1:10 ratio, effective June 11, 2026
- Approved by stockholders at the 2026 annual meeting on May 21, 2026
- Board approved the split on June 1, 2026
- No fractional shares issued — holders of fractional shares receive one full post-split share
- CUSIP number changed to 825693500
- Outstanding warrants, RSUs, and convertible preferred stock adjusted proportionally
- Total authorized shares of common and preferred stock unchanged
Financial Impact
Not specified
Risk Factors
- Potential delisting risk if Nasdaq compliance not achieved after the reverse split
- Reverse splits often precede dilutive equity offerings in micro-cap issuers
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-028301 |
| Exhibit: ex3-1.htm | 0001493152-26-028301 |
| Document: 0001493152-26-028301-index-headers.html | 0001493152-26-028301 |
| Document: 0001493152-26-028301-index.html | 0001493152-26-028301 |
| Document: 0001493152-26-028301.txt | 0001493152-26-028301 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | 8-K | $3.49 $4.04 | ▲ +15.76% | ▲ +16.09% | $4.17 (+19.48%) |
Jul 13, 2026 11w ago | 3 | $2.96 $4.07 | ▲ +37.50% | ▲ +34.32% | $4.17 (+40.88%) |
Jul 1, 2026 13w ago | 3 | $3.58 $3.09 | ▼ −13.69% | ▼ −13.27% | $4.17 (+16.48%) |
Jun 11, 2026 16w ago | 8-K | $3.91 $2.92 | ▼ −25.32% | ▼ −27.10% | $4.17 (+6.65%) |
May 7, 2026 21w ago | 8-K | $6.89 $4.84 | ▲ +29.75% | ▲ +29.97% | $4.17 (+39.48%) |
May 1, 2026 22w ago | 8-K | $6.92 $5.33 | ▲ +22.98% | ▲ +28.23% | $4.17 (+39.74%) |
Mar 10, 2026 29w ago | 8-K | $0.9010 $0.7250 | ▼ −19.53% | ▼ −20.06% | $4.17 (+362.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access